Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enarodustat for anemia in multiple myeloma
ChiCTR2500114033Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in anaemia comparing Enarodustat arm with Placebo arm (2 arms). Primary endpoint: Hemoglobin level. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
enarodustat
03
Conditions
anaemia
Beyond the preview
Go deeper on ChiCTR2500114033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114033.